Source: Annual Congress 2011 - Lung development and neoplasia
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
R. G. Marangoni, A. P. P. Velosa, E. E. Parra, J. de Moraes, V. L. Capelozzi, W. R. Teodoro, N. H. Yoshinari (Sao Paulo, Brazil). Up-regulation of collagen type V mRNA in a model of systemic sclerosis. Eur Respir J 2011; 38: Suppl. 55, 3803

Member's Comments

No comment yet.

Related content which might interest you: Increased mRNA expression of collagen V gene in pulmonary fibrosis of systemic sclerosis Source: Annual Congress 2009 - Bronchoalveolar lavage and phenotyping in diffuse parenchymal lung disease Year: 2009 Type V collagen nasal tolerance regulates collagen mRNA synthesis in pulmonary remodeling of experimental systemic sclerosis Source: Annual Congress 2008 - Interstitial lung disease in systemic and vascular disorders Year: 2008 Transcription factor FOXp3 is over expressed in BALT of systemic sclerosis model induced by collagen V nasal tolerance Source: Annual Congress 2011 - Animal models of airway inflammation Year: 2011 Abnormal collagen type V deposition in lung fibroblast is correlated with a worse pulmonary function in systemic sclerosis Source: Annual Congress 2007 - Miscellaneous interstitial lung diseases related to systemic and other diseases Year: 2007 Collagen V and decorin is involved in systemic sclerosis pulmonary fibrosis Source: Annual Congress 2011 - The ageing pulmonary interstitium Year: 2011 Collagen V nasal tolerance promotes decrease in topoisomerase-1 and pulmonary fibrosis of systemic sclerosis model Source: Annual Congress 2010 - Experimental approaches in pulmonary fibrosis Year: 2010 Arterial type V collagen disorganization in patients with systemic sclerosis: preliminary study Source: Annual Congress 2007 - Miscellaneous interstitial lung diseases related to systemic and other diseases Year: 2007 Refractory remodeling of intrapulmonary arteries by type V collagen, apoptosis and endothelial activation in experimental systemic sclerosis Source: Annual Congress 2010 - Experimental pulmonary hypertension Year: 2010 Pulmonary interstitium remodeling by collagen V is associated with profibrotic cytocines in experimental systemic sclerosis Source: Annual Congress 2007 - Miscellaneous interstitial lung diseases related to systemic and other diseases Year: 2007 Systemic sclerosis patients‘ sera recognize collagen V in experimental scleroderma lung fibrosis Source: Annual Congress 2011 - The ageing pulmonary interstitium Year: 2011 Polymorphisms in the type IV collagen alpha3 gene and the risk of COPD Source: Eur Respir J 2008; 32: 35-41 Year: 2008 Tridimensional reconstruction and biochemical profile of collagen V alpha-2 chain in lung fibroblasts culture from patients with systemic sclerosis indicate a defect in fibrillogenesis microarchitecture Source: Annual Congress 2010 - Pulmonary circulation I Year: 2010 Overexpression of angiotensin II type 1 receptor (AGTR1) and lymphatic vasculature rarefaction is present in scleroderma with pulmonary compromised Source: Annual Congress 2012 - Diffuse parenchymal lung disease II Year: 2012 Expression of hyaluronidase by interstitial myofibroblasts and epithelial cells is associated with fibrosis extension, clinical forms and pulmonary function stage in patients with systemic sclerosis Source: Annual Congress 2010 - Pathogenesis of diffuse parenchymal lung disease Year: 2010 Nasal tolerance promotes increase in tumoral type V collagen protein synthesis and vascular apoptosis in the mouse lung chemical carcinogenesis Source: Annual Congress 2010 - Novel cellular mechanisms in lung disease Year: 2010 The microRNA cluster 17/92 regulates the expression of the bone morphogenetic protein receptor type II involved in the pathogenesis of pulmonary hypertension Source: Annual Congress 2009 - Pathobiology of pulmonary hypertension Year: 2009 Regulation of γ-GCS gene expression by TGF-β in type II epithelial cells: role for Fra-1/AP-1/ARE Source: Eur Respir J 2002; 20: Suppl. 38, 96s Year: 2002 Serum type III procollagen peptide in idiopathic pulmonary fibrosis: peptide levels and anti-fibrosis therapy Source: Eur Respir J 2005; 26: Suppl. 49, 30s Year: 2005 Abnormalities between down regulation of cyclooxygenase-2 and up-regulation of grow factors in patients with systemic sclerosis Source: Annual Congress 2011 - Rare diffuse lung diseases Year: 2011 Imbalanced expression of the type I TGF-beta receptors ALK-1 in pulmonary fibrosis Source: Annual Congress 2009 - Mechanisms of pulmonary inflammation and fibrosis Year: 2009